RxDoctor Payments Data

Eileen Hunt, NP

Adult Health · West Babylon, NYNPI 1528767464

Payments from drug & device makers

$1,343in general payments, 2019–2025

Across 59 payments — averaging $22.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$296
  • AstraZeneca$243
  • Otsuka America Pharmaceutical, Inc.$197
  • Exact Sciences$150
  • Amgen$108
  • Daiichi Sankyo Inc.$80
  • plus $269 from 10 others

What the payments were for

  • Food & beverage$1,343100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,343 in reported general payments places this provider in the 70th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Medicare billing

Part B allowed, 2024
$49,307
Medicare patients
373
Services billed
716

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin39$53,938
EliquisApixaban40$42,315
OzempicSemaglutide25$35,521
MounjaroTirzepatide20$22,285
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$21,082
XareltoRivaroxaban14$16,894
Breo ElliptaFluticasone/Vilanterol11$7,475
Levothyroxine Sodium233$2,696
Atorvastatin Calcium243$2,260
Rosuvastatin Calcium128$2,113
Metoprolol Succinate143$1,930
SynthroidLevothyroxine Sodium33$1,926
Pantoprazole Sodium107$1,750
Albuterol Sulfate HfaAlbuterol Sulfate54$1,475
Omega-3 Acid Ethyl Esters11$1,107

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$296$53,93839 claims
GSKTrelegy Ellipta, Breo Ellipta$14$28,55834 claims
Lilly USA, LLCMounjaro$54$22,28520 claims
AbbVieSynthroid$16$1,92633 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,828 adult health providers in New York.

Other adult health in West Babylon

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →